[{"data":1,"prerenderedAt":246},["ShallowReactive",2],{"options:asyncdata:$edqCtX92v0:/blogs/kenya-records-35867-new-cancer-cases-in-latest-globocan-2024-estimates:0":3},{"blogPost":4,"otherBlogs":83},{"id":5,"date":6,"date_gmt":6,"guid":7,"modified":6,"modified_gmt":6,"slug":9,"status":10,"type":11,"link":12,"title":13,"content":15,"excerpt":18,"author":20,"featured_media":21,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":25,"categories":27,"tags":29,"class_list":30,"featured_media_src_url":38,"_links":39},697,"2026-07-10T06:36:34",{"rendered":8},"https://wp.ncikenya.go.ke/?p=697","kenya-records-35867-new-cancer-cases-in-latest-globocan-2024-estimates","publish","post","https://wp.ncikenya.go.ke/2026/07/10/kenya-records-35867-new-cancer-cases-in-latest-globocan-2024-estimates/",{"rendered":14},"Kenya Records 35,867 New Cancer Cases in Latest GLOBOCAN 2024 Estimates",{"rendered":16,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Nairobi, Kenya – The latest Global Cancer Observatory (GLOBOCAN) 2024 estimates indicate that 35,867 new cancer cases are diagnosed annually in Kenya, while 22,888 people die from the disease each year. The report also estimates that 76,165 people are living with cancer within five years of diagnosis. Compared to the GLOBOCAN 2022 estimates, the 2024 report reflects lower estimated numbers of new cancer cases, cancer-related deaths, and five-year prevalence. However, cancer remains a significant public health challenge, stressing the need for sustained investment in prevention, early detection, diagnosis, treatment, research, and palliative care.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>According to the report, breast cancer remains the most commonly diagnosed cancer in Kenya, accounting for 5,822 new cases (16.2%), followed by cervical cancer with 4,294 cases (12.0%), prostate cancer with 3,601 cases (10.0%), oesophageal cancer with 2,532 cases (7.1%), and colorectal cancer with 2,525 cases (7.0%).\u003C/strong>\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"439\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1024x439.png\" alt=\"\" class=\"wp-image-699\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1024x439.png 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-300x129.png 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-768x330.png 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1536x659.png 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1.png 1871w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The report also highlights the leading causes of cancer-related deaths. Breast cancer remains the leading cause of cancer mortality, claiming 2,882 lives annually, followed by cervical cancer (2,606 deaths), oesophageal cancer (2,353 deaths), prostate cancer (2,199 deaths), and colorectal cancer (1,481 deaths).\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Among men, prostate cancer continues to be the most commonly diagnosed cancer, accounting for 3,601 new cases (25.9%), followed by oesophageal, colorectal, stomach, and leukaemia. Among women, breast cancer remains the leading cancer with 5,822 new cases (26.5%), followed by cervical cancer, colorectal cancer, oesophageal cancer, and ovarian cancer.\u003C/strong>\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"495\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-1024x495.png\" alt=\"\" class=\"wp-image-698\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-1024x495.png 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-300x145.png 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-768x371.png 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2-1536x742.png 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan2.png 1674w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The findings reaffirm the urgent need to strengthen Kenya&#8217;s cancer control efforts through enhanced public awareness, timely screening, early diagnosis, equitable access to quality treatment, palliative care, and sustained investment in cancer research. Early detection remains one of the most effective strategies for improving survival rates and reducing cancer-related deaths.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The National Cancer Institute of Kenya (NCI-K) continues to coordinate the implementation of the National Cancer Control Strategy 2023–2027, which provides a comprehensive framework for reducing the country&#8217;s cancer burden through five strategic pillars: cancer prevention and early detection; diagnosis, treatment and palliative care; governance and financing; cancer registration, surveillance and research; and monitoring, evaluation, and strategic information.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>While Kenya has made significant progress in expanding access to cancer services, strengthening county cancer programmes, improving cancer surveillance, and fostering strategic partnerships, the latest GLOBOCAN estimates demonstrate that cancer remains a major public health challenge requiring increased investment and a whole-of-society response.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>NCI-K calls upon all Kenyans to prioritize healthy lifestyles, participate in recommended cancer screening programmes, seek medical attention promptly for persistent symptoms, and support national efforts aimed at reducing the burden of cancer. The Institute also urges continued collaboration among government, county governments, healthcare providers, development partners, academia, the private sector, and communities to accelerate progress towards a future where fewer Kenyans are diagnosed with cancer and more survive the disease.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>The GLOBOCAN 2024 estimates, published by the International Agency for Research on Cancer (IARC), provide the latest global and country-specific cancer incidence and mortality statistics and serve as an important resource for informing cancer control planning, policy development, and resource allocation.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",false,{"rendered":19,"protected":17},"\u003Cp>Nairobi, Kenya – The latest Global Cancer Observatory (GLOBOCAN) 2024 estimates indicate that 35,867 new cancer cases are diagnosed annually in Kenya, while 22,888 people die from the disease each year. The report also estimates that 76,165 people are living with cancer within five years of diagnosis. Compared to the GLOBOCAN 2022 estimates, the 2024 [&hellip;]\u003C/p>\n",1,699,"open","","standard",{"pagelayer_contact_templates":26,"_pagelayer_content":23,"footnotes":23},[],[28],4,[],[31,11,32,33,34,35,36,37],"post-697","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-updates","https://wp.ncikenya.go.ke/wp-content/uploads/2026/07/2024-globocan1-1024x439.png",{"self":40,"collection":46,"about":49,"author":52,"replies":56,"version-history":59,"predecessor-version":62,"wp:featuredmedia":66,"wp:attachment":69,"wp:term":72,"curies":79},[41],{"href":42,"targetHints":43},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/697",{"allow":44},[45],"GET",[47],{"href":48},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts",[50],{"href":51},"https://wp.ncikenya.go.ke/wp-json/wp/v2/types/post",[53],{"embeddable":54,"href":55},true,"https://wp.ncikenya.go.ke/wp-json/wp/v2/users/1",[57],{"embeddable":54,"href":58},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=697",[60],{"count":20,"href":61},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/697/revisions",[63],{"id":64,"href":65},700,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/697/revisions/700",[67],{"embeddable":54,"href":68},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/699",[70],{"href":71},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=697",[73,76],{"taxonomy":74,"embeddable":54,"href":75},"category","https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=697",{"taxonomy":77,"embeddable":54,"href":78},"post_tag","https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=697",[80],{"name":81,"href":82,"templated":54},"wp","https://api.w.org/{rel}",[84,137,193],{"id":85,"date":86,"date_gmt":86,"guid":87,"modified":86,"modified_gmt":86,"slug":89,"status":10,"type":11,"link":90,"title":91,"content":93,"excerpt":95,"author":20,"featured_media":96,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":97,"categories":99,"tags":100,"class_list":101,"featured_media_src_url":104,"_links":105},701,"2026-08-14T13:52:50",{"rendered":88},"https://wp.ncikenya.go.ke/?p=701","the-nci-k-frequently-asked-questions","https://wp.ncikenya.go.ke/2026/08/14/the-nci-k-frequently-asked-questions/",{"rendered":92},"THE NCI-K FREQUENTLY ASKED QUESTIONS",{"rendered":94,"protected":17},"\n\u003Cdiv data-wp-interactive=\"core/file\" class=\"wp-block-file\">\u003Cobject data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\" type=\"application/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of FREQUENTLY ASKED QUESTIONS.\">\u003C/object>\u003Ca id=\"wp-block-file--media-f588684c-c8b2-4c62-b33a-0be4d748438d\" href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\">FREQUENTLY ASKED QUESTIONS\u003C/a>\u003Ca href=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/08/FREQUENTLY-ASKED-QUESTIONS.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-f588684c-c8b2-4c62-b33a-0be4d748438d\">Download\u003C/a>\u003C/div>\n",{"rendered":23,"protected":17},0,{"pagelayer_contact_templates":98,"_pagelayer_content":23,"footnotes":23},[],[20],[],[102,11,32,33,34,36,103],"post-701","category-uncategorized",null,{"self":106,"collection":111,"about":113,"author":115,"replies":117,"version-history":120,"predecessor-version":123,"wp:attachment":127,"wp:term":130,"curies":135},[107],{"href":108,"targetHints":109},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701",{"allow":110},[45],[112],{"href":48},[114],{"href":51},[116],{"embeddable":54,"href":55},[118],{"embeddable":54,"href":119},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=701",[121],{"count":20,"href":122},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701/revisions",[124],{"id":125,"href":126},703,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/701/revisions/703",[128],{"href":129},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=701",[131,133],{"taxonomy":74,"embeddable":54,"href":132},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=701",{"taxonomy":77,"embeddable":54,"href":134},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=701",[136],{"name":81,"href":82,"templated":54},{"id":138,"date":139,"date_gmt":139,"guid":140,"modified":139,"modified_gmt":139,"slug":142,"status":10,"type":11,"link":143,"title":144,"content":146,"excerpt":148,"author":20,"featured_media":150,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":151,"categories":153,"tags":154,"class_list":155,"featured_media_src_url":157,"_links":158},683,"2026-06-19T10:09:43",{"rendered":141},"https://wp.ncikenya.go.ke/?p=683","nci-kenya-supports-historic-launch-of-kilifi-countys-first-cancer-centre","https://wp.ncikenya.go.ke/2026/06/19/nci-kenya-supports-historic-launch-of-kilifi-countys-first-cancer-centre/",{"rendered":145},"NCI-Kenya Supports Historic Launch of Kilifi County&#8217;s First Cancer Centre.",{"rendered":147,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute of Kenya (NCI-K) joined Kilifi County, development partners, and stakeholders in celebrating a major milestone in Kenya&#8217;s cancer control efforts with the official commissioning of the first-ever Cancer Centre at Kilifi County Referral Hospital.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The landmark event, hosted by H.E. Governor Gideon Maitha Mung&#8217;aro, was attended by H.E. Arnaud Suquet, Ambassador of France to Kenya, Mr. Amin Mawji, OBE, Diplomatic Representative of the Aga Khan Development Network in Kenya, representatives from the Ministry of Health, county leadership, development partners, and other key stakeholders committed to strengthening cancer care services in Kenya.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The establishment of the Cancer Centre marks a significant step towards improving access to quality cancer care for residents of Kilifi County and the wider Coastal region. For many years, patients seeking oncology services have been forced to travel long distances to access specialized treatment, often resulting in financial hardship, delayed care, and poor treatment outcomes. The introduction of chemotherapy services at the facility will bring life-saving treatment closer to patients and improve timely access to cancer care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">NCI-Kenya played a critical role in supporting the realization of this milestone as part of its mandate to coordinate and promote cancer prevention, early detection, treatment, palliative care, research, and partnerships across the country. Through close collaboration with the Ministry of Health, Kilifi County Government, the National Cancer Control Programme, development partners, and healthcare institutions, NCI-K continues to support efforts aimed at decentralizing cancer services and strengthening cancer care infrastructure at the county level.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The launch of the centre aligns with Kenya&#8217;s broader objective of expanding access to comprehensive cancer care and reducing disparities in service delivery. It also reflects the growing impact of strategic partnerships in advancing the national cancer control agenda.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Looking ahead, Kilifi County has outlined plans to further strengthen the facility by establishing comprehensive oncology services, including radiotherapy through the acquisition of a Linear Accelerator (LINAC) and enhanced breast cancer screening through investment in digital mammography technology. These developments will contribute significantly to improving cancer outcomes through timely diagnosis and treatment.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Speaking during the event, leaders acknowledged the importance of collaboration in making the project a reality. NCI-Kenya was recognized as one of the key partners whose technical support, coordination, and commitment contributed to the successful establishment of the Cancer Centre. The commissioning of the Kilifi County Cancer Centre marks a significant milestone in Kenya&#8217;s journey towards equitable cancer care. The facility brings hope to patients and families by expanding access to quality cancer services closer to home and reducing the burden of travelling long distances for treatment. NCI-Kenya remains committed to working with national and county governments, healthcare providers, and development partners to strengthen cancer prevention, early detection, treatment, and care services across the country.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",{"rendered":149,"protected":17},"\u003Cp>The National Cancer Institute of Kenya (NCI-K) joined Kilifi County, development partners, and stakeholders in celebrating a major milestone in Kenya&#8217;s cancer control efforts with the official commissioning of the first-ever Cancer Centre at Kilifi County Referral Hospital. The landmark event, hosted by H.E. Governor Gideon Maitha Mung&#8217;aro, was attended by H.E. Arnaud Suquet, Ambassador [&hellip;]\u003C/p>\n",684,{"pagelayer_contact_templates":152,"_pagelayer_content":23,"footnotes":23},[],[20],[],[156,11,32,33,34,35,36,103],"post-683","https://wp.ncikenya.go.ke/wp-content/uploads/2026/06/WhatsApp-Image-2026-06-18-at-11.54.40-PMG.jpeg",{"self":159,"collection":164,"about":166,"author":168,"replies":170,"version-history":173,"predecessor-version":176,"wp:featuredmedia":180,"wp:attachment":183,"wp:term":186,"curies":191},[160],{"href":161,"targetHints":162},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/683",{"allow":163},[45],[165],{"href":48},[167],{"href":51},[169],{"embeddable":54,"href":55},[171],{"embeddable":54,"href":172},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=683",[174],{"count":20,"href":175},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/683/revisions",[177],{"id":178,"href":179},685,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/683/revisions/685",[181],{"embeddable":54,"href":182},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/684",[184],{"href":185},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=683",[187,189],{"taxonomy":74,"embeddable":54,"href":188},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=683",{"taxonomy":77,"embeddable":54,"href":190},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=683",[192],{"name":81,"href":82,"templated":54},{"id":194,"date":195,"date_gmt":195,"guid":196,"modified":198,"modified_gmt":198,"slug":199,"status":10,"type":11,"link":200,"title":201,"content":203,"excerpt":205,"author":20,"featured_media":96,"comment_status":206,"ping_status":206,"sticky":17,"template":23,"format":24,"meta":207,"categories":209,"tags":210,"class_list":211,"featured_media_src_url":104,"_links":213},739,"2026-10-16T05:02:06",{"rendered":197},"https://wp.ncikenya.go.ke/?p=739","2026-10-17T07:02:56","nci-k-ceo-dr-elias-melly-delivers-keynote-address-at-international-cancer-registries-conference-in-tanzania","https://wp.ncikenya.go.ke/2026/10/16/nci-k-ceo-dr-elias-melly-delivers-keynote-address-at-international-cancer-registries-conference-in-tanzania/",{"rendered":202},"NCI-K CEO Dr. Elias Melly Delivers Keynote Address at International Cancer Registries Conference in Tanzania",{"rendered":204,"protected":17},"\n\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Arusha, Tanzania | 14–16 October 2026\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, delivered a keynote address at the IACR–AFCRN–NORA Scientific Conference held at Mount Meru Hotel in Arusha, Tanzania, from 14 to 16 October 2026.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761-1024x768.jpg\" alt=\"\" class=\"wp-image-740\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761-1024x768.jpg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761-300x225.jpg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761-768x576.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761-1536x1152.jpg 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818761.jpg 1600w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>NCI-K CEO, Dr. Elias Melly Delivery his Keynote Address at the IACR, Tanzania.\u003C/em>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Dr. Melly was featured as the keynote speaker on the opening day of the conference, on 14 October 2026, underscoring Kenya’s participation in regional and international efforts to strengthen cancer prevention and control through research, reliable cancer data and effective surveillance systems.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The scientific conference brought together cancer registry professionals, researchers and public health experts to share scientific evidence, exchange knowledge and discuss approaches to improving cancer registration, surveillance, research and the use of cancer data to inform policy and public health interventions.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Regional and International Partnerships in Cancer Control\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference provided a platform for collaboration among the International Association of Cancer Registries (IACR), the African Cancer Registry Network (AFCRN) and NORA, alongside scientific sessions involving NORA–REACCT–CAN. These collaborative platforms brought together expertise and research from across Africa and other regions to address shared challenges in cancer registration and control.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818758-768x1024-1.jpg\" alt=\"\" class=\"wp-image-741\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818758-768x1024-1.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818758-1152x1536.jpg 1152w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818758.jpg 1200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>Dr. Melly (centre)with outgoing IACR President, Dr. Charles Wiggins (right), and the incoming president, Dr. Dabber Wanna (left)\u003C/em>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">For NCI-K, participation in such regional and international scientific engagements reinforces the importance of partnerships in strengthening cancer surveillance, building institutional capacity and generating evidence to guide national cancer control priorities.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Effective cancer control depends on access to quality, timely and reliable data on cancer incidence, mortality, survival and patterns of diagnosis. Strong cancer registration systems help governments and health institutions understand the burden of cancer, identify gaps in services, plan interventions and assess progress in prevention, early detection, treatment and care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference programme featured discussions on population-based cancer registration, cancer registry governance and standards, data quality and accessibility, cervical cancer screening, cancer survival, and translating registry data into policy and public health action.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya Advances National Childhood Cancer Registry Development\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s contribution to the scientific programme also featured work towards strengthening childhood cancer surveillance. On 15 October 2026, Gladys Chesumbai, Head of the National Cancer Registry at the National Cancer Institute of Kenya presented on “Delphi Consensus for a Standardized National Childhood Cancer Registry Minimum Dataset in Kenya.”\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818752-768x1024-1.jpg\" alt=\"\" class=\"wp-image-742\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818752-768x1024-1.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818752-225x300.jpg 225w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818752-1152x1536.jpg 1152w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818752.jpg 1200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Gladys Chesumbai, Head of Cancer Registry at NCI-K\u003C/em>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The presentation formed part of a plenary session examining the burden of childhood, adolescent and early-onset cancers. Standardising the minimum dataset for a national childhood cancer registry is an important area of work in strengthening the consistency and quality of information collected on childhood cancers.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Reliable childhood cancer data can support a better understanding of the disease burden, inform research and planning, and provide an evidence base for decisions aimed at improving services for children affected by cancer.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s participation in this scientific exchange highlights the value of sharing national experiences and learning from international expertise as the country advances its cancer surveillance and registry development agenda.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Advancing the National Cancer Control Agenda Through Collaboration\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conference’s focus on cancer registration, research, data standards and evidence-informed decision-making aligns with the broader need for coordinated approaches to cancer prevention and control across the region.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">As a statutory body established under the Cancer Prevention and Control Act, No. 15 of 2012, NCI-K is mandated to spearhead and coordinate cancer prevention and control in Kenya through the implementation of the National Cancer Control Strategy.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Engagement in regional and international platforms enables the Institute to participate in scientific discussions, strengthen professional networks and contribute to collective efforts to improve cancer information systems and public health responses.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818757-1024x683.jpg\" alt=\"\" class=\"wp-image-743\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818757-1024x683.jpg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818757-300x200.jpg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818757-767x512.jpg 767w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/10/818757.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Through continued collaboration with national, regional and international stakeholders, NCI-K remains committed to advancing evidence-informed cancer control and supporting efforts towards a cancer-free nation.\u003C/p>\n\n\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",{"rendered":23,"protected":17},"closed",{"pagelayer_contact_templates":208,"_pagelayer_content":23,"footnotes":23},[],[20],[],[212,11,32,33,34,36,103],"post-739",{"self":214,"collection":219,"about":221,"author":223,"replies":225,"version-history":228,"predecessor-version":232,"wp:attachment":236,"wp:term":239,"curies":244},[215],{"href":216,"targetHints":217},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/739",{"allow":218},[45],[220],{"href":48},[222],{"href":51},[224],{"embeddable":54,"href":55},[226],{"embeddable":54,"href":227},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=739",[229],{"count":230,"href":231},3,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/739/revisions",[233],{"id":234,"href":235},748,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/739/revisions/748",[237],{"href":238},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=739",[240,242],{"taxonomy":74,"embeddable":54,"href":241},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=739",{"taxonomy":77,"embeddable":54,"href":243},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=739",[245],{"name":81,"href":82,"templated":54},1792672537900]